Peter W. Sonsini, 10% Owner at Adaptimmune Therapeutics PLC (ADAP), bought 7,500,000 shares at $0.67 ($5.0M) on 2020-01-24, disclosed to the SEC on 2020-01-28.
Open-market purchase of $5.0M ADAP by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| Filing → |
| IMRA | SELL | 2022-01-14 | $42K | — | Filing → |
| MTCR | SELL | 2021-12-27 | $649K | — | Filing → |
| IMRA | SELL | 2021-12-27 | $1.1M | — | Filing → |